Endeavor

Moffitt Opens Flagship Outpatient Cancer Center at Speros

Moffitt Speros Outpatient Center anchors first phase of 775-acre Speros campus and brings proton therapy to Pasco County

Using Machine Learning To Predict Response in Acute Myeloid Leukemia

Probabilities shown in real time can inform better decision-making

Moffitt Using New Approach To Treat Pancreatic Cancer

Some patients who are ineligible for pancreatic cancer surgery can benefit from the Trans-Arterial Micro-Perfusion (TAMP™) therapy platform at Moffitt Cancer Center.

Physician-Scientist Explores How AI Can Improve Treatment Decisions

Ciara Freeman, MD, PhD, and her colleagues are combining data in an AI platform to uncover patterns that clinicians can use to guide real-time decisions 

The Promise of Radiopharmaceuticals

Breakthrough therapies deliver radiation directly to cancer cells while minimizing harm to surrounding healthy tissue

TIL Therapy Research Expanded to Bladder Cancer

Almost half of patients enrolled in a Moffitt trial responded to the cellular immunotherapy

Can Hybrid Immunotherapy Improve Solid Tumor Treatment?

Moffitt researchers test CAR-TIL cells combining tumor navigation and targeted attack

Endocrinologist Navigates Gray Area Between Malignant and Benign

Prerna Dogra, MD, explains that endocrine tumors can cause complex problems, even when they are not cancerous

Accelerating Impact Through Global Partnership

Moffitt is redefining the cancer treatment landscape through a series of groundbreaking international partnerships